TOPICS | n/N (%)* |
---|---|
Diagnosis related | |
• Interpreting laboratory test results for secondary osteoporosis | 756/882 (85.7) |
• What laboratory tests to order to rule out secondary osteoporosis | 755/883 (85.5) |
• Interpreting BMD results | 743/893 (83.2) |
• When to order lateral AP lumbar spine x-ray scan | 734/884 (83.0) |
• When to order BMD testing | 704/886 (79.5) |
• Interpreting lateral AP lumbar spine x-ray scan | 679/872 (77.9) |
• Clinical examination for vertebral fracture | 646/885 (73.0) |
Treatment related | |
• Duration of pharmacotherapy | 839/886 (94.7) |
• Adverse effects of pharmacotherapy | 780/890 (87.6) |
• Types of pharmacotherapy | 760/886 (85.8) |
• Dose of pharmacotherapy | 705/887 (79.5) |
• Calcium dose | 650/882 (73.7) |
• Vitamin D dose | 622/869 (71.6) |
AP—anterior-posterior, BMD—bone mineral density.
↵* Percentages are based on the proportion of respondents who somewhat agreed, agreed, or strongly agreed with a statement regarding the need for education on a specific osteoporosis-related topic.